Phase II Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Mucoid Exopolysaccharide Pseudomonas Aeruginosa Immune Globulin for Cystic Fibrosis
Clinical trial NCT00004747 · COMPLETED
Trial details
- NCT number
- NCT00004747
- Sponsor
- National Center for Research Resources (NCRR)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1995-07-01
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.